BLOISE, RAFFAELLA
 Distribuzione geografica
Continente #
NA - Nord America 733
EU - Europa 623
AS - Asia 374
AF - Africa 4
OC - Oceania 1
Totale 1.735
Nazione #
US - Stati Uniti d'America 729
CN - Cina 370
IE - Irlanda 201
IT - Italia 85
FI - Finlandia 79
UA - Ucraina 76
DE - Germania 52
FR - Francia 48
SE - Svezia 44
GB - Regno Unito 26
BE - Belgio 4
CA - Canada 4
CH - Svizzera 2
IN - India 2
MU - Mauritius 2
NL - Olanda 2
TN - Tunisia 2
AU - Australia 1
CZ - Repubblica Ceca 1
GR - Grecia 1
HU - Ungheria 1
IR - Iran 1
JP - Giappone 1
PT - Portogallo 1
Totale 1.735
Città #
Chandler 212
Dublin 201
Jacksonville 111
Nanjing 103
Ashburn 66
Beijing 57
Nanchang 38
Princeton 38
Lawrence 35
Hebei 31
Shanghai 29
Shenyang 29
Medford 28
Wilmington 28
Changsha 24
Helsinki 23
Jiaxing 22
Hangzhou 16
Boardman 12
Seattle 11
Woodbridge 11
San Genesio Ed Uniti 10
Milan 8
New York 6
Tianjin 6
Verona 6
Alghero 4
Ann Arbor 4
Brussels 4
Kunming 4
Norwalk 4
Rome 4
Toronto 4
Washington 4
Chicago 3
Dearborn 3
Fairfield 3
Falls Church 3
Andover 2
Bex 2
Bologna 2
Des Moines 2
Los Angeles 2
Naples 2
Pune 2
Sassari 2
Zhengzhou 2
Assemini 1
Bari 1
Brno 1
Cagliari 1
Cento 1
Cherasco 1
Città Di Castello 1
Como 1
Dallas 1
Dalmine 1
Forest City 1
Genoa 1
Gostar 1
Lanzhou 1
Las Vegas 1
Lisbon 1
Ningbo 1
Palermo 1
Pescia 1
Piombino 1
Piscataway 1
Pittsburgh 1
Rockville 1
Rutigliano 1
San Francisco 1
San Jose 1
Saronno 1
Sestu 1
Taizhou 1
Tappahannock 1
Tokyo 1
Treviglio 1
Turin 1
Vicenza 1
Viterbo 1
Totale 1.258
Nome #
Tachicardia Ventricolare Polimorfa Catecolaminergica 127
Gene-specific therapy for inherited arrhythmogenic diseases 74
Images in cardiovascular medicine. Endocardial implantation of a cardioverter-defibrillator in a 13-month-old child affected by long-QT syndrome and syndactyly. 73
Clinical presentation and outcome of Brugada syndrome diagnosed with the new 2013 criteria 62
Clinical profile and genetic basis of Brugada syndrome in the Chinese population. 61
Clinical and Molecular Characterization of Patients with Catecholominergic Polymorphic Ventricular Tachycardia. 60
Hydroquinidine Prevents Life-Threatening Arrhythmic Events in Patients With Short QT Syndrome 59
Interplay Between Genetic Substrate, QTc Duration, and Arrhythmia Risk in Patients With Long QT Syndrome 58
Basi genetiche della morte cardiaca improvvisa 57
L-TYPE CALCIUM CHANNEL DISEASE 57
Postmortem molecular analysis in victims of sudden unexplained death 57
A Molecular Link between the Sudden Infant Death Syndrome and the Long-QT Syndrome. 57
Clinical utility gene card for: Catecholaminergic polymorphic ventricular tachycardia (CPVT). 56
Timothy Syndrome 55
CaMKII inhibition rectifies arrhythmic phenotype in a patient-specific model of catecholaminergic polymorphic ventricular tachycardia. 55
Gene-specific therapy with mexiletine reduces arrhythmic events in patients with long QT syndrome type 3 54
Catecholaminergic polymorphic ventricular tachycardia: successful emergency treatment with intravenous propranolol. 54
Low penetrance mutations and compound heterozygosity in LQTS: phenotypic consequences and implications for the clinical presentation of the disease 52
La sindrome di Brugada: epidemiologia, stratificazione del rischio e management clinico. 51
Romano-Ward and other congenital long QT syndromes 48
La tachicardia ventricolare polimorfa catecolaminergica 46
Gating Properties of SCN5A Mutations and the Response to Mexiletine in Long-QT Syndrome Type 3 Patients 44
Programmed Electrical Stimulation in Brugada Syndrome: How reproducible are the results? 43
Test diagnostici in cardiologia 42
Mutations in the Cardiac Ryanodine Receptor Gene (hRyR2) Underlie Catecholaminergic Polymorphic Ventricular Tachycardia 41
Association of Hydroxychloroquine with QTc Interval in Patients with COVID-19 41
Efficacy and Limitations of Quinidine in Patients with Brugada Syndrome 39
Unexpected Risk Profile of a Large Pediatric Population With Brugada Syndrome 38
Novel insights in the natural history of Short QT Syndrome 32
Identification of a SCN5A founder mutation causing sudden death, Brugada syndrome, and conduction blocks in Southern Italy 31
Unusual retrospective prenatal findings in a male newborn with Timothy syndrome type 1 30
Natural History of Brugada Syndrome: Insights for risk stratification and management 30
Sudden Cardiac Death and Genetic Ion Channelopathies: Long QT, Brugada, Short QT, Catecholaminergic Polymorphic Ventricular Tachycardia, and Idiopathic Ventricular Fibrillation 29
Outcomes of Patients With Catecholaminergic Polymorphic Ventricular Tachycardia Treated With β-Blockers 26
Polymorphisms in the NOS1AP gene modulate QT interval duration and risk of arrhythmias in the long QT syndrome 25
Totale 1.764
Categoria #
all - tutte 6.384
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.384


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020417 131 154 2 14 1 15 0 18 2 39 38 3
2020/2021193 17 21 6 17 2 24 6 25 16 26 22 11
2021/2022158 3 1 5 0 2 4 5 14 8 10 29 77
2022/2023576 58 54 7 59 45 70 0 32 237 1 10 3
2023/2024204 27 28 7 26 16 34 19 20 3 0 8 16
2024/20251 1 0 0 0 0 0 0 0 0 0 0 0
Totale 1.764